$5.62
-0.05-0.88%
À la clôture: Sep 4, 5:00 PM EST
$5.58
-0.0425-0.76%
Après les heures: 4:10 PM EST
ARS Pharmaceuticals Inc
SPRYNASDAQ
ARS Pharmaceuticals Earnings & Forecasts
ARS Pharmaceuticals (SPRY) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
ARS Pharmaceuticals Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.50 | $-0.53 | $-0.46 | $-0.47 |
| Actual | $-0.63 | $-0.61 | $-0.42 | $-0.52 |
| Surprise | -26.0% | -15.1% | +8.70% | -10.6% |
| Revenue | ||||
| Estimate | $31.4M | $22.1M | $25.6M | $28.6M |
| Actual | $33.7M | $22.7M | $28.1M | $32.5M |
| Surprise | +7.07% | +2.44% | +9.52% | +13.6% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.31 | $-0.31 | $-0.35 | $-0.21 |
| Revenue | ||||
| Consensus | $44.8M | $30.7M | — | — |